Expand patient access to precision medicine by running CANCERPLEX in your lab.

Do you want to offer the most clinically actionable test to your patients?

Do you want to perform the test in your lab and stop sending out tumor samples?

Do you want to leverage current laboratory setup  with minimal investment in R&D and bioinformatics?

Do you want to stay at the leading edge by receiving constant innovation and support ?

If “yes”, then KEW has a solution for you.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

KEW’s workflow for comprehensive genomic profiling with CANCERPLEX®  in your lab

Based on decades of experience and pioneering work in clinical cancer genomics and molecular pathology, KEW has developed end-to-end Comprehensive Genomic Profiling solutions for sequencing tumor DNA, identifying clinically-actionable genomic variants and providing a personalized report based on their individual molecular profile within 1-2 weeks. 

          

Patient tumor samples are sequenced using CANCERPLEX Reagents on Illumina MiSeq or NextSeq instruments for targeted capture and enrichment of >400 clinically-relevant, cancer-associated genes.

Data files from the NGS instrument are automatically pushed through the CANCERPLEX  server to KEW’s cloud-based server for variant detection with KEW’s robust, high-performance, bioinformatics pipeline.

 

Rigorous filters are then automatically applied to ensure only high-confident variant calls are interpreted and matched with therapeutic options.

A personalized patient report is then generated containing the clinically-actionable genetic variants found in the patient’s tumor with matched therapeutic options.

Trained CANCERPLEX technologists and physicians can access NGS QC data and patient reports through a secured, web-based portal.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Implementing CANCERPLEX  in your lab

KEW will provide hands-on assistance for implementing the NGS workflow in your lab under CLIA regulation as a lab developed test. Implementation is customizable to fit your needs and can be completed in as little as 12 weeks. 

Implementation process includes the following

LAB SETUP

KEW will provide guidance for setting up your lab infrastructure and selecting equipments for performing CANCERPLEX on-site.

TRAINING

KEW will provide protocols and hands-on training to help you adopt our optimized NGS sequencing workflow. 

NETWORK CONNECTIVITY

KEW will work with your IT department to set up a secure connection for data transfer.

SECURE PORTAL

KEW will set up a web-based portal for easy access to our NGS QC dashboard and patient reports.

VALIDATION

KEW will provide samples and guidance to validate CANCERPLEX as a lab developed test under CLIA regulation.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

ADVANTAGES OF PARTNERING WITH KEW

Expert Resources

Access to KEW’s experienced experts in bioinformatics and genomic testing, as well as proprietary knowledge base GENEKEEPER®.

Minimal Investment

No need for assay development and bioinformatics expenditures. Minimal cost for maintainance and upgrades.

New Product Development

Ongoing access to new product developments and improvements

Ongoing Support

Ongoing support for increasing visibility and market access

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Expand Patient Access To Precision Medicine Today

Contact Us

Call us

855.225.4068

Email

kewcustomercare@kewinc.com

Location

840 Memorial Drive, 4th Floor Cambridge, MA 02139